Skip to contentSkip to content
What we do
How we work
Impact
Who we are
News
Publications
What we do
How we work
Impact
Who we are
News
Publications
News & blog
Keeping you up to date with the latest developments in science, policy and health
S1R1C1
Blog
Antisense oligonucleotides: new therapies for n = 1 rare diseases
Wednesday August 7, 2024
Some of these diseases are so rare that only a single case (n = 1) or a few cases (n = few) are known globally. Therefore, rare disease patients need highly individualised treatments. Antisense oligonucleotides promise hope
Blog
How do we close the diversity gap in genomics?
Thursday July 11, 2024
PHG policy analysts Tanya Brigden and Bhavya Krishnan bring perspectives from their respective fields to discuss how to close the diversity gap
Blog
A much needed call to action – the launch of the Global Heat Health Resilience statement
Tuesday June 25, 2024
The consensus statement, initiated by the Physiological Society, calls on governments to recognise the challenge that rising temperatures are presenting to human health.
Blog
The European Health Data Space Regulation has arrived
Thursday June 20, 2024
The European Health Data Space Regulation has arrived but will its mandatory sharing requirement be its tour de force or Achilles’ heel?
Blog
Future-proofing protection against pandemics
Tuesday April 30, 2024
Advances in computational biology are opening new doors for vaccine development and the momentum to develop pan-spectrum vaccines for viral infections has never been greater.
Blog
Biomarkers and their clinical utility in prevention
Tuesday April 30, 2024
Our recommendations to PROPHET-EU call for a broader suite of evidence around biomarkers and their clinical utility in prevention
News
Reflections and key questions on data and AI for health
Friday April 26, 2024
The regulation and governance of AI, data and digital health was the theme for this year’s WYNG-Hatton conference.
Blog
Viruses for good – the case for phages
Wednesday April 10, 2024
The case for the widespread use of phage therapies is gaining momentum, with several significant reports published in the last few months. Using phages to tackle antimicrobial resistence is showing particular promise. In the blog, we look at the what needs to happen next to make these viruses work for good
Blog
What do patents tell us about the nature and trajectory of medical AI?
Friday April 5, 2024
What can we learn by examining the patenting trends for medical AI or machine learning over 20 years? The answer is a surprising amount.
1
2
3
4
5
10
❯
Last »
S2R1C1